Freenome

company

About

Freenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.

Details

Last Funding Type
Corporate Round
Last Funding Money Raised
$290M
Industries
Biotechnology,Health Care,Health Diagnostics,Personal Health
Founded date
Jan 1, 2014
Number Of Employee
251 - 500
Operating Status
Active
Legal Name
Freenome Inc.

Freenome is a biotech company developing accurate, accessible, and non-invasive disease screening products for proactively treating cancer and other diseases at their most manageable stages.

The company is developing a simple blood test to detect early-stage cancer and make treatments more effective and provides a platform that helps design healthy conditions for an individual based on his/her cell-free genome. The company aims to reinvent disease management through systematized early detection and intervention.

Charles Roberts, Gabriel Otte, Riley Ennis, and Michael Otte launched the company in 2014 in South San Francisco, California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
8
$1.09B
Freenome has raised a total of $1.09B in funding over 2 rounds. Their latest funding was raised on Jan 11, 2022 from a Corporate Round round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 11, 2022 Corporate Round $290M 1 Roche Detail
Dec 7, 2021 Series D $300M 31 Perceptive Advisors
RA Capital Management
Detail
Aug 26, 2020 Series C $270M 22 Bain Capital Life Sciences
Perceptive Advisors
Detail
Jul 24, 2019 Series B $160M 16 Polaris Partners
RA Capital Management
Detail
Aug 28, 2017 Series A $7M 12 Section 32 Detail

Investors

Number of Lead Investors
Number of Investors
11
50
Freenome is funded by 50 investors. Roche and Perceptive Advisors are the most recent investors.
Investor Name Lead Investor Funding Round
Roche Yes Corporate Round
Perceptive Advisors Yes Series D
RA Capital Management Yes Series D
Loxbridge Research Yes Seed
Andreessen Horowitz Series D
ArrowMark Partners Series D
Artis Ventures (AV) Series D
Bain Capital Life Sciences Series D
BrightEdge Fund Series D
Byers Capital Series D

Employee Profiles

Number of Employee Profiles
23
Freenome has 23 current employee profiles, including Executive Lyndal Hesterberg
Executive
Employee
Employee
Employee
Executive